These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 563400)
61. [IMP-cyclohydrolase/transformylase from ehrlich-ascites carcinoma (author's transl)]. Geiger R; Guglielmi H Hoppe Seylers Z Physiol Chem; 1975 Jun; 356(6):819-25. PubMed ID: 241692 [TBL] [Abstract][Full Text] [Related]
62. Purification and biological characterization of human hepatopoietin A, a polypeptide growth factor for hepatocytes. Zarnegar R; Michalopoulos G Cancer Res; 1989 Jun; 49(12):3314-20. PubMed ID: 2524251 [TBL] [Abstract][Full Text] [Related]
65. Increased endonuclease activity in an extract from mouse Ehrlich ascites tumor cells which had been treated with a partially purified interferon preparation: dependence of double-stranded RNA; Brown GE; Lebleu B; Kawakita M; Shaila S; Sen GC; Lengyel P Biochem Biophys Res Commun; 1976 Mar; 69(1):114-22. PubMed ID: 1259747 [No Abstract] [Full Text] [Related]
66. Occurrence of alpha-D-galactosyl-containing glycoproteins on Ehrlich tumor cell membranes. Eckhardt AE; Goldstein IJ Biochemistry; 1983 Nov; 22(23):5280-9. PubMed ID: 6652064 [TBL] [Abstract][Full Text] [Related]
67. Purification and characterization of a lysosomal form and a variant form of beta-glucuronidase from the rat basophil leukaemia tumour. Schwartz LB; Austen KF Biochem J; 1981 Mar; 193(3):663-70. PubMed ID: 7305955 [TBL] [Abstract][Full Text] [Related]
68. Purification and characterization of an antitumor principle from Streptococcus hemolyticus, Su strain. Yoshida J; Yoshimura M; Takamura S; Kobayashi S Jpn J Cancer Res; 1985 Mar; 76(3):213-23. PubMed ID: 3922840 [TBL] [Abstract][Full Text] [Related]
69. Procedure for the large-scale production of mouse interferons with Ehrlich ascites tumor cells. Broeze R; Jayaram B; Slattery E; Taira H; Lengyel P Methods Enzymol; 1981; 78(Pt A):143-7. PubMed ID: 6173580 [No Abstract] [Full Text] [Related]
70. Purification and characterization of thymidylate synthetase in the liver of the mouse bearing Ehrlich ascites tumor. Asanagi M; Moriyama Y; Fujimura S Arch Biochem Biophys; 1988 Dec; 267(2):749-57. PubMed ID: 3214180 [TBL] [Abstract][Full Text] [Related]
71. Interferon action: transcriptional control of a gene specifying a 56,000-Da protein in Ehrlich ascites tumor cells. Engel DA; Samanta H; Brawner ME; Lengyel P Virology; 1985 Apr; 142(2):389-97. PubMed ID: 4060577 [TBL] [Abstract][Full Text] [Related]
72. Purification of mouse interferon on specifically purified immunoadsorbent. Hajnicka V; Fuchsberger N; Borecký L Arch Immunol Ther Exp (Warsz); 1977; 25(5):619-22. PubMed ID: 597010 [TBL] [Abstract][Full Text] [Related]
73. Purification and characterization of mouse serum interferon. Liu JL; Peng SY Zhonghua Min Guo Wei Sheng Wu Xue Za Zhi; 1975 Jun; 8(2):111-9. PubMed ID: 812679 [TBL] [Abstract][Full Text] [Related]
74. Partial purification of human interferon by affinity chromatography. Anfinsen CB; Bose S; Corley L; Gurari-Rotman D Proc Natl Acad Sci U S A; 1974 Aug; 71(8):3139-42. PubMed ID: 4370251 [TBL] [Abstract][Full Text] [Related]
75. Purification of a chalone-like inhibitor for Ehrlich ascites mammary carcinoma cells from bovine mammary gland. Lehmann W; Samtleben R; Graetz H; Langen P Eur J Cancer Clin Oncol; 1983 Jan; 19(1):101-7. PubMed ID: 6221930 [TBL] [Abstract][Full Text] [Related]